文献速递肝胆胰外科围术期管理与 ERAS

良性 versus 恶性疾病行远端胰腺切除术的短期外科并发症与死亡率:NSQIP分析

Short-term surgical morbidity and mortality of distal pancreatectomy performed for benign versus malignant diseases: a NSQIP analysis.
PubMed 文献 · Surg Endosc · 2019-10-09

本研究基于NSQIP 2014-2016年远端胰腺切除术(DP)数据,比较良性疾病(DP-B)与恶性疾病(DP-M)的30天结局。多变量分析显示两组死亡率及胰瘘风险无显著差异,但DP-M组出血和复合并发症显著更高;血栓栓塞仅在与开腹途径联合时与DP-M显著相关。

要点

  • DP-M与DP-B的30天死亡率及胰瘘风险无显著差异。
  • DP-M组术后出血和复合并发症发生率显著高于DP-B组。
  • 开腹DP-M血栓栓塞风险显著增加,微创途径下该风险无统计学意义。

核心结论

  • DP-M与术后出血、血栓栓塞和脓毒症风险显著高于DP-B相关,但死亡率无显著增加。
  • 开腹途径下DP-M术后血栓栓塞风险增加,微创途径下该风险无统计学意义。

研究设计与样本

  • 回顾性队列研究,使用NSQIP靶向胰腺切除术参与用户文件2014-2016年数据。
  • 采用多变量logistic回归评估良恶性与30天结局的关联,并纳入临床和/或统计学显著混杂因素。
  • 在开腹和腹腔镜DP亚组中重复相同分析。

主要发现

  • 最常见手术指征为恶性疾病,占1894例(53%)。
  • 30天死亡率DP-B为0.4%,DP-M为1.3%。
  • 多变量分析显示两组死亡率和胰瘘风险无显著差异。
  • DP-M组出血(p=0.002)和复合并发症(p=0.01)显著更高。
  • 复合并发症中,血栓栓塞仅在与开腹途径联合时与DP-M显著相关(OR 2.1,p=0.0004)。

临床怎么用

  • 对恶性指征行远端胰腺切除术患者,应加强术后出血和血栓栓塞监测。
  • 考虑微创途径可能降低恶性DP患者开腹相关的血栓栓塞风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIM: Distal pancreatectomy (DP) accounts for 25% of all pancreatic resections. Complications following DP occur in around 40% of the cases. Our aim is to analyze short-term surgical outcomes of DP based on whether the indication for resection was benign or malignant pathology, as well as the effect of the surgical approach, open versus laparoscopic on morbidity and mortality. METHODS: We studied all patients undergoing DP from the National Surgery Quality Improvement Program (NSQIP) targeted pancreatectomy participant use file from 2014 to 2016. The patients were divided into 2 groups, those who underwent DP for benign diseases (DP-B) and those who underwent DP for malignant diseases (DP-M). We performed multivariate logistic regression to evaluate the association between benign or malignant distal pancreatectomies and 30-day outcomes. We included clinically and/or statistically significant confounders into the models. We also conducted the same analysis in the subgroups of open and laparoscopic DP. RESULTS: Three thousand five hundred and seventy-nine patients underwent distal pancreatectomy. The most common indication for surgery was malignant disease in 1894 (53%). Thirty-day mortality occurred in 0.4% of DP-B compared to 1.3% DP-M. On multivariate analysis, no significant difference was found in mortality or in the risk of pancreatic fistula between the 2 groups. Bleeding (p = 0.002) and composite morbidity (p = 0.01) were significantly higher in the DP-M group. Among composite morbidities, thromboembolism was significantly associated with DP-M (OR 2.1, p = 0.0004) only when performed with an open approach. CONCLUSION: DP-M is associated with a significantly higher risk of post-operative bleeding, thromboembolism, and sepsis compared to DP-B but no significant increase in mortality. When further analyzing the impact of the operative approach on morbidity, there was an increased rate of post-operative thromboembolic in the DP-M group when the surgery was performed in an open manner and this increased risk was no longer statistically significant if the DP-M was performed using a minimally invasive approach.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Daniel FE, Tamim HM, Hosni MN, et al. Short-term surgical morbidity and mortality of distal pancreatectomy performed for benign versus malignant diseases: a NSQIP analysis. Surg Endosc. 2019. PMID: 31598880. doi:10.1007/s00464-019-07163-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。